Significantly Elevated Systemic Levels after Occlusive Application of Topical Tacrolimus in Atopic Dermatitis

Publisher： Karger

E-ISSN： 1421-9832|212|3|260-261

ISSN： 1018-8665

Source： Dermatology, Vol.212, Iss.3, 2006-04, pp. : 260-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Low Systemic Exposure after Repeated Topical Application of Pimecrolimus (Elidel®, SD Z ASM 981) in Patients with Atopic Dermatitis

By  

Dermatology, Vol. 204, Iss. 1, 2002-04 ,pp. : 63-68

Karger

Access to resources Recommend Favorite

Topical Tacrolimus for Atopic Dermatitis: Euphoria and Vigilance

By  

Dermatology, Vol. 203, Iss. 1, 2001-09 ,pp. : 1-2

Karger

Access to resources Recommend Favorite

Safe and Effective Treatment of Refractory Facial Lesions in Atopic Dermatitis Using Topical Tacrolimus following Corticosteroid Discontinuation

By  

Dermatology, Vol. 203, Iss. 1, 2001-09 ,pp. : 32-37

Karger

Access to resources Recommend Favorite

Clinical and Cytological Effects of Pimecrolimus Cream 1% after Resolution of Active Atopic Dermatitis Lesions by Topical Corticosteroids: A Randomized Controlled Trial

By  

Dermatology, Vol. 222, Iss. 1, 2010-12 ,pp. : 36-48

Karger

Access to resources Recommend Favorite

Eczema herpeticum during Treatment of Atopic Dermatitis with 0.1% Tacrolimus Ointment

By  

Dermatology, Vol. 201, Iss. 3, 2000-11 ,pp. : 249-251

Karger

Access to resources Recommend Favorite